Balyasny Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-200,000
Closed -$9.05M 1721
2017
Q1
$9.05M Sell
200,000
-399,700
-67% -$17M 0.04% 531
2016
Q4
$24.3M Buy
599,700
+136,342
+29% +$5.37M 0.13% 224
2016
Q3
$314K Buy
463,358
+363,358
+363% +$14.6M ﹤0.01% 816
2016
Q2
$4.18M Hold
100,000
0.03% 544
2016
Q1
$4.02M Buy
+100,000
New +$4.02M 0.02% 586

Other funds holding SNY

Balyasny Asset Management's SNY Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Sanofi (SNY) in Q1 2026: 833,780 shares worth $40.2M. The stake represents 0.05% of the portfolio and ranks #414 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in SNY as recently as Q3 2025.

Balyasny Asset Management first reported a position in SNY in Q4 2015 and has held it in 27 quarters since. The position peaked at $120M in Q2 2017. 741 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Balyasny Asset Management held 833,780 shares of Sanofi worth $40.2M as of Q1 2026.
  • Sanofi was a new Balyasny Asset Management position in Q1 2026.
  • Sanofi made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #414 holding.
  • Balyasny Asset Management first reported a position in Sanofi in Q4 2015 and has held it in 27 quarters since.
  • Balyasny Asset Management's Sanofi position peaked at $120M in Q2 2017.
  • 741 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.